Oral semaglutide represents a paradigm shift in GLP-1 therapy accessibility, with extensive real-world evidence from 19 studies confirming comparable effectiveness and tolerability to injectable formulations in routine clinical scenarios [65]
10.1016/j.bbrc.2013.08.055 62
Why is weight regain after GLP-1s so problematic People using GLP-1 medications can experience significant muscle loss while they are taking the medication, which can have a long-term detrimental effect on their health
What they found (summary): NAD+ levels decline linearly with age in all tissues Sirtuins are glucose sensors , activated during caloric restriction and fasting The decline in NAD+ leads to pseudohypoxia in aging cells Supplementation with NAD+ precursors in animal models restores sirtuin activity Therapeutic perspectives: NMN, NR, sirtuin activators, CD38 inhibitors Why it matters: This is the reference article for the entire field
Stay Hydrated : Drink enough water, especially if you experience diarrhea, to help manage discomfort